Asian companies can tap into their expertise in fermentation when it comes to creating nutritional products for the GLP-1 drug user, says Rinka Banerjee, a former R&D director of Hindustan Unilever’s foods business in South Asia.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.